BAYER AG-REG (1BAYN.MI) Fundamental Analysis & Valuation

BIT:1BAYN • DE000BAY0017

40.015 EUR
+0.39 (+0.98%)
Last: Mar 11, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This 1BAYN.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

1BAYN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 54 industry peers in the Pharmaceuticals industry. 1BAYN has a bad profitability rating. Also its financial health evaluation is rather negative. 1BAYN is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. 1BAYN.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1BAYN was profitable.
  • In the past year 1BAYN had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: 1BAYN reported negative net income in multiple years.
  • In the past 5 years 1BAYN always reported a positive cash flow from operatings.
1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCF1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B -10B

1.2 Ratios

  • 1BAYN has a worse Return On Assets (-3.46%) than 70.37% of its industry peers.
  • Looking at the Return On Equity, with a value of -13.95%, 1BAYN is doing worse than 70.37% of the companies in the same industry.
Industry RankSector Rank
ROA -3.46%
ROE -13.95%
ROIC N/A
ROA(3y)-2.76%
ROA(5y)-0.83%
ROE(3y)-10.29%
ROE(5y)-3.43%
ROIC(3y)N/A
ROIC(5y)N/A
1BAYN.MI Yearly ROA, ROE, ROIC1BAYN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • In the last couple of years the Operating Margin of 1BAYN has declined.
  • Looking at the Gross Margin, with a value of 58.76%, 1BAYN is doing worse than 64.81% of the companies in the same industry.
  • 1BAYN's Gross Margin has improved in the last couple of years.
  • 1BAYN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.76%
OM growth 3Y-2.05%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5Y1.79%
1BAYN.MI Yearly Profit, Operating, Gross Margins1BAYN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. 1BAYN.MI Health Analysis

2.1 Basic Checks

  • 1BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, 1BAYN has about the same amount of shares outstanding.
  • 1BAYN has about the same amout of shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, 1BAYN has an improved debt to assets ratio.
1BAYN.MI Yearly Shares Outstanding1BAYN.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
1BAYN.MI Yearly Total Debt VS Total Assets1BAYN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • Based on the Altman-Z score of 0.78, we must say that 1BAYN is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of 1BAYN (0.78) is worse than 75.93% of its industry peers.
  • 1BAYN has a debt to FCF ratio of 10.93. This is a negative value and a sign of low solvency as 1BAYN would need 10.93 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 10.93, 1BAYN is doing worse than 66.67% of the companies in the same industry.
  • A Debt/Equity ratio of 1.23 is on the high side and indicates that 1BAYN has dependencies on debt financing.
  • 1BAYN's Debt to Equity ratio of 1.23 is on the low side compared to the rest of the industry. 1BAYN is outperformed by 70.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF 10.93
Altman-Z 0.78
ROIC/WACCN/A
WACC7.05%
1BAYN.MI Yearly LT Debt VS Equity VS FCF1BAYN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 1.01 indicates that 1BAYN should not have too much problems paying its short term obligations.
  • 1BAYN has a Current ratio of 1.01. This is in the lower half of the industry: 1BAYN underperforms 79.63% of its industry peers.
  • 1BAYN has a Quick Ratio of 1.01. This is a bad value and indicates that 1BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.63, 1BAYN is doing worse than 85.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.63
1BAYN.MI Yearly Current Assets VS Current Liabilites1BAYN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. 1BAYN.MI Growth Analysis

3.1 Past

  • 1BAYN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.99%.
  • 1BAYN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.00% yearly.
  • The Revenue has decreased by -2.21% in the past year.
  • The Revenue has been growing slightly by 1.94% on average over the past years.
EPS 1Y (TTM)-11.99%
EPS 3Y-17.58%
EPS 5Y-7%
EPS Q2Q%-85.26%
Revenue 1Y (TTM)-2.21%
Revenue growth 3Y-3.51%
Revenue growth 5Y1.94%
Sales Q2Q%-2.41%

3.2 Future

  • Based on estimates for the next years, 1BAYN will show a small growth in Earnings Per Share. The EPS will grow by 6.22% on average per year.
  • The Revenue is expected to grow by 2.62% on average over the next years.
EPS Next Y5.3%
EPS Next 2Y6.88%
EPS Next 3Y9.93%
EPS Next 5Y6.22%
Revenue Next Year0.65%
Revenue Next 2Y1.52%
Revenue Next 3Y2.48%
Revenue Next 5Y2.62%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1BAYN.MI Yearly Revenue VS Estimates1BAYN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
1BAYN.MI Yearly EPS VS Estimates1BAYN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. 1BAYN.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • 1BAYN is valuated reasonably with a Price/Earnings ratio of 9.01.
  • 92.59% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 26.15. 1BAYN is valued rather cheaply when compared to this.
  • Based on the Price/Forward Earnings ratio of 8.55, the valuation of 1BAYN can be described as reasonable.
  • 1BAYN's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1BAYN is cheaper than 96.30% of the companies in the same industry.
  • 1BAYN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.27.
Industry RankSector Rank
PE 9.01
Fwd PE 8.55
1BAYN.MI Price Earnings VS Forward Price Earnings1BAYN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1BAYN is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
  • 85.19% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.43
EV/EBITDA 39.48
1BAYN.MI Per share data1BAYN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.7
PEG (5Y)N/A
EPS Next 2Y6.88%
EPS Next 3Y9.93%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1BAYN.MI Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.29%, 1BAYN is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.91, 1BAYN is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.82, 1BAYN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.29%

5.2 History

  • The dividend of 1BAYN decreases each year by -46.01%.
Dividend Growth(5Y)-46.01%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 1BAYN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3.51%
EPS Next 2Y6.88%
EPS Next 3Y9.93%
1BAYN.MI Yearly Income VS Free CF VS Dividend1BAYN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B -10B

More info and screens

Find the best dividend stocksShow peers with best dividend

1BAYN.MI Fundamentals: All Metrics, Ratios and Statistics

BAYER AG-REG

BIT:1BAYN (3/11/2026, 7:00:00 PM)

40.015

+0.39 (+0.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-04
Earnings (Next)05-12
Inst Owners51.38%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap39.31B
Revenue(TTM)45.58B
Net Income(TTM)-3.62B
Analysts73.1
Price Target42.8 (6.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.29%
Yearly Dividend0.13
Dividend Growth(5Y)-46.01%
DP-3.51%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.81%
Min EPS beat(2)-69.54%
Max EPS beat(2)71.16%
EPS beat(4)3
Avg EPS beat(4)12.34%
Min EPS beat(4)-69.54%
Max EPS beat(4)71.16%
EPS beat(8)6
Avg EPS beat(8)6.56%
EPS beat(12)8
Avg EPS beat(12)2.06%
EPS beat(16)11
Avg EPS beat(16)2.37%
Revenue beat(2)1
Avg Revenue beat(2)-0.84%
Min Revenue beat(2)-2.42%
Max Revenue beat(2)0.74%
Revenue beat(4)1
Avg Revenue beat(4)-1.32%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)0.74%
Revenue beat(8)3
Avg Revenue beat(8)-1.36%
Revenue beat(12)3
Avg Revenue beat(12)-2.42%
Revenue beat(16)6
Avg Revenue beat(16)-1.51%
PT rev (1m)1.42%
PT rev (3m)31.64%
EPS NQ rev (1m)-5.26%
EPS NQ rev (3m)-4.76%
EPS NY rev (1m)-4.2%
EPS NY rev (3m)-3.83%
Revenue NQ rev (1m)-0.54%
Revenue NQ rev (3m)1.05%
Revenue NY rev (1m)-0.2%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 9.01
Fwd PE 8.55
P/S 0.86
P/FCF 11.43
P/OCF 6.63
P/B 1.52
P/tB N/A
EV/EBITDA 39.48
EPS(TTM)4.44
EY11.1%
EPS(NY)4.68
Fwd EY11.7%
FCF(TTM)3.5
FCFY8.75%
OCF(TTM)6.03
OCFY15.07%
SpS46.39
BVpS26.41
TBVpS-23.14
PEG (NY)1.7
PEG (5Y)N/A
Graham Number51.37
Profitability
Industry RankSector Rank
ROA -3.46%
ROE -13.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.76%
FCFM 7.54%
ROA(3y)-2.76%
ROA(5y)-0.83%
ROE(3y)-10.29%
ROE(5y)-3.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.98%
ROCE(5y)8.08%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.05%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5Y1.79%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF 10.93
Debt/EBITDA 18.64
Cap/Depr 89.3%
Cap/Sales 5.46%
Interest Coverage N/A
Cash Conversion 346.9%
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 0.63
Altman-Z 0.78
F-Score6
WACC7.05%
ROIC/WACCN/A
Cap/Depr(3y)49.46%
Cap/Depr(5y)55.83%
Cap/Sales(3y)5.73%
Cap/Sales(5y)5.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.99%
EPS 3Y-17.58%
EPS 5Y-7%
EPS Q2Q%-85.26%
EPS Next Y5.3%
EPS Next 2Y6.88%
EPS Next 3Y9.93%
EPS Next 5Y6.22%
Revenue 1Y (TTM)-2.21%
Revenue growth 3Y-3.51%
Revenue growth 5Y1.94%
Sales Q2Q%-2.41%
Revenue Next Year0.65%
Revenue Next 2Y1.52%
Revenue Next 3Y2.48%
Revenue Next 5Y2.62%
EBIT growth 1Y-1416.9%
EBIT growth 3Y-5.49%
EBIT growth 5YN/A
EBIT Next Year55.31%
EBIT Next 3Y16.4%
EBIT Next 5Y10.93%
FCF growth 1Y-25.07%
FCF growth 3Y-6.06%
FCF growth 5Y6.77%
OCF growth 1Y-19.56%
OCF growth 3Y-5.83%
OCF growth 5Y3.89%

BAYER AG-REG / 1BAYN.MI FAQ

What is the fundamental rating for 1BAYN stock?

ChartMill assigns a fundamental rating of 2 / 10 to 1BAYN.MI.


What is the valuation status of BAYER AG-REG (1BAYN.MI) stock?

ChartMill assigns a valuation rating of 6 / 10 to BAYER AG-REG (1BAYN.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for BAYER AG-REG?

BAYER AG-REG (1BAYN.MI) has a profitability rating of 2 / 10.


What are the PE and PB ratios of BAYER AG-REG (1BAYN.MI) stock?

The Price/Earnings (PE) ratio for BAYER AG-REG (1BAYN.MI) is 9.01 and the Price/Book (PB) ratio is 1.52.


Can you provide the expected EPS growth for 1BAYN stock?

The Earnings per Share (EPS) of BAYER AG-REG (1BAYN.MI) is expected to grow by 5.3% in the next year.